[Federal Register Volume 74, Number 184 (Thursday, September 24, 2009)]
[Notices]
[Pages 48759-48760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-23001]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]


Risk Communication Advisory Committee; Notice of Meeting

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.

    Name of Committee: Risk Communication Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on November 12, 2009, 
from 8 a.m. to 5 p.m. and November 13, 2009, from 8 a.m. to 2 p.m.
    Location: The Hilton Hotel, 8727 Colesville Rd., Silver Spring, 
MD 20910.
    Contact Person: Lee L. Zwanziger, Office of the Commissioner, 
Office of Policy, Planning and Preparedness, Office of Planning, 
Food and Drug Administration, 5600 Fishers Lane, rm. 14-90, 
Rockville, MD 20857, 301-827-2895, FAX: 301-827-4050, e-mail: 
[email protected], or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington, DC area), code 8732112560. 
Please call the Information Line for up-to-date information on this 
meeting. A notice in the Federal Register about last minute 
modifications that impact a previously announced advisory committee 
meeting cannot always be published quickly enough to provide timely 
notice. Therefore, you should always check the agency's Web site and 
call the

[[Page 48760]]

appropriate advisory committee hot line/phone line to learn about 
possible modifications before coming to the meeting.
    Agenda: On November 12 and 13, 2009, the Committee will discuss 
strategies and programs designed to communicate with the public 
about the risks and benefits of FDA-regulated products so as to 
facilitate optimal use of these products. For more specific agenda 
topics, please visit the following Web site and scroll down to the 
appropriate advisory committee link (http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm), or call the FDA Advisory 
Committee Information Line as detailed under ``Contact Person''. FDA 
intends to provide specific agenda topics at both these locations no 
later than 15 days before the meeting.
    FDA intends to make background material available to the public 
no later than 2 business days before the meeting. If FDA is unable 
to post the background material on its Web site prior to the 
meeting, the background material will be made publicly available at 
the location of the advisory committee meeting, and the background 
material will be posted on FDA's Web site after the meeting. 
Background material is available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the 
appropriate advisory committee link.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person on or before 
November 4, 2009. Oral presentations from the public will be 
scheduled between approximately 1 p.m. and 2 p.m. on November 12, 
2009, and between approximately 10:30 a.m. and 11:30 a.m. on 
November 13, 2009. Those desiring to make formal oral presentations 
should notify the contact person and submit a brief statement of the 
general nature of the evidence or arguments they wish to present, 
the names and addresses of proposed participants, and an indication 
of the approximate time requested to make their presentation on or 
before November 4, 2009. Time allotted for each presentation may be 
limited. If the number of registrants requesting to speak is greater 
than can be reasonably accommodated during the scheduled open public 
hearing session, FDA may conduct a lottery to determine the speakers 
for the scheduled open public hearing session. The contact person 
will notify interested persons regarding their request to speak by 
November 5, 2009.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to 
electrical outlets.
    FDA welcomes the attendance of the public at its advisory 
committee meetings and will make every effort to accommodate persons 
with physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Lee Zwanziger at 
least 7 days in advance of the meeting.
    FDA is committed to the orderly conduct of its advisory 
committee meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for 
procedures on public conduct during advisory committee meetings.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: September 18, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-23001 Filed 9-23-09; 8:45 am]
BILLING CODE 4160-01-S